ESCRS Showcase

Article

Brief round-up of some of the exciting developments we can expect to see from the show floor at ESCRS.

IOL for demanding patients

Oculentis has introduced the LENTIS Comfort intraocular lens (IOL) designed with demanding cataract patients in mind.

Booth number: S128

Website: http://www.ocululentis.com/

Tissuesparing laser therapy

Iridex has announced a combination therapy that enables laser surgery to be delivered through an intraocular fibre-optic probe.

Booth number: N208

Website: http://www.iridex.com/

Static and kinetic ­perimetry

The AP-7000, from Kowa Optimed, is an ocular perimeter able to provide both static and kinetic perimetry, as well as fundus-orientated perimetry.

Kowa Optimed will also be offering visitors to the booth the chance to win a 3D LCD monitor in a free prize draw.

Booth number: S145

Website: http://www.kowa.eu/

Compact perimeter

The Oculus Easyfield C is an efficient compact perimeter capable of conducting static perimetry of up to 30° on glaucoma patients.

The Oculus Easyfield C enables shortened threshold examinations during glaucoma screenings, but also offers a novel possibility to interpret the visual field data. With no further need of a dedicated computer system, this setup provides us a portable device with extended glaucoma screening abilities.

The automated perimetry device has an integrated bowl with a radius of 30 cm and the distance corrected lens is adapted to the Goldmann standard. This achieves the ISOnorm 12866 for perimeters. Additionally, the system features a chin rest that allows for a more comfortable patient experience.

Booth number: S155

Website: http://www.oculus.de/

Recent Videos
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.